Ticker > Company >

Syngene Internatl. share price

Syngene International Ltd.

NSE: SYNGENE BSE: 539268 SECTOR: Business Support  2.2 L   561   108

406.65
+3.40 (0.84%)
NSE: 24 Jul 4:00 PM

Price Summary

Today's High

₹ 408.25

Today's Low

₹ 399

52 Week High

₹ 728.6

52 Week Low

₹ 380

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

16415.21 Cr.

Enterprise Value

15691.31 Cr.

No. of Shares

40.37 Cr.

P/E

53.84

P/B

3.52

Face Value

₹ 10

Div. Yield

0.31 %

Book Value (TTM)

₹  115.5

CASH

723.9 Cr.

DEBT

0 Cr.

Promoter Holding

52.59 %

EPS (TTM)

₹  7.55

Sales Growth

1.5%

ROE

6.58 %

ROCE

8.92%

Profit Growth

-34.85 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 26Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1.5%
3 Year2.35%
5 Year9.45%

Profit Growth

1 Year-34.85%
3 Year-13.62%
5 Year-5.46%

ROE%

1 Year6.58%
3 Year9.77%
5 Year11.31%

ROCE %

1 Year8.92%
3 Year12.36%
5 Year13.17%

Debt/Equity

0

Price to Cash Flow

19.75

Interest Cover Ratio

16.2

CFO/PAT (5 Yr. Avg.)

2.03152597094293

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 52.59 0.00
Mar 2026 52.68 0.00
Dec 2025 52.68 0.00
Sep 2025 52.68 0.00
Jun 2025 52.68 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 102.5 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 16.2.
  • The Company has been maintaining an effective average operating margins of 27.10922% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -16127.6048 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.03152597094293.
  • The company has a high promoter holding of 52.59%.

 Limitations

  • The company has shown a poor profit growth of -13.6162417873616% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.34824220999719% for the Past 3 years.
  • The company is trading at a high PE of 53.84.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 948.4 799.3 830.1 834.4 960
Total Expenditure 638.4 631.2 652.6 649.7 675.7
Operating Profit 310 168.1 177.5 184.7 284.3
Other Income 18.4 16.6 14.2 14.5 21.6
Interest 10.1 5.9 7.4 6.2 6.5
Depreciation 89.6 94.6 100.1 97.1 95.3
Exceptional Items 0 0 0 -65.8 -7.4
Profit Before Tax 228.7 84.2 84.2 30.1 196.7
Tax 54.3 10.2 18 13.6 48.5
Profit After Tax 174.4 74 66.2 16.5 148.2
Adjusted EPS (Rs) 4.33 1.84 1.64 0.41 3.68

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 2601.4 3193.5 3203.1 3373.3 3423.8
Total Expenditure 1863.6 2260.9 2324.4 2455.8 2614.8
Operating Profit 737.8 932.6 878.7 917.5 809
Other Income 108.4 72.6 88 70.5 72.5
Interest 24.1 45.2 29.5 31.2 26
Depreciation 309.7 359.1 368.8 367.2 387.1
Exceptional Items -30.7 0 -11.1 32 -73.2
Profit Before Tax 481.7 600.9 557.3 621.6 395.2
Tax 87.9 127.9 90.8 153.6 90.3
Net Profit 393.8 473 466.5 468 304.9
Adjusted EPS (Rs.) 9.83 11.78 11.6 11.63 7.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 400.8 401.4 402 402.5 402.9
Total Reserves 2891.2 3217.5 3789.5 4236.4 4300.9
Borrowings 531.5 489 100 0 0
Other N/C liabilities 440.7 291.4 394 409.5 355.9
Current liabilities 1231.5 1157.2 1098.6 1328.6 1418.9
Total Liabilities 5495.7 5768.4 5784.1 6377 6478.6
Assets
Net Block 2354.3 2211.8 2276.8 2206.9 2455.5
Capital WIP 346.4 126.2 758.3 875.4 535.9
Intangible WIP 0 0 1.3 4.7 5.3
Investments 270.6 116.4 435 870.1 1118.9
Loans & Advances 150.7 164.5 230.3 173.1 142.3
Other N/C Assets 170.1 794.2 230.6 212.9 344.5
Current Assets 2203.6 2355.3 1851.8 2033.9 1876.2
Total Assets 5495.7 5768.4 5784.1 6377 6478.6
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 481.7 600.9 557.3 621.6 395.2
Adjustment 381.3 375.3 286.3 366.1 427.6
Changes in Assets & Liabilities -176.6 -4.1 168.2 227.6 52.4
Tax Paid -104.2 -133.7 -98.4 -101.5 -44.2
Operating Cash Flow 582.2 838.4 913.4 1113.8 831
Investing Cash Flow -610.8 -685.1 -382.6 -810.4 -766.2
Financing Cash Flow -31.3 -340.2 -536.3 -136.5 -177.8
Net Cash Flow -59.9 -186.9 -5.5 166.9 -113

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 52.68 52.68 52.68 52.68 52.59
biocon limited 52.41 52.41 52.41 52.41 52.32
biocon limited employee w... 0.26 0.26 0.26 0.26 0.26
kiran mazumdar shaw 0.01 0.01 0.01 0.01 0.01
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 47.32 47.32 47.32 47.32 47.41
dsp nifty smallcap 250 in... - - - - 4.61
government of singapore 2.94 2.91 - 2.89 2.13
hsbc mutual fund - hsbc m... - - - - 1.55
icici prudential nifty sm... - - - - 5.30
life insurance corporatio... - - - - 1.78
mirae asset nifty 500 hea... - - - - 1.85
nippon life india trustee... - - - - 7.73
sbi nifty smallcap 250 in... - - - - 1.95
dsp arbitrage fund 3.34 4.32 - 4.75 -
government pension fund g... 2.57 2.57 1.85 1.82 -
icici prudential s&p bse ... - - - 5.38 -
lic new pension plus grow... - - - 1.78 -
mirae asset multicap fund... - - - 3.27 -
nippon life india trustee... - - - 5.99 -
uti balanced advantage fu... - - - 1.16 -
dsp nifty midcap 150 etf - - 4.60 - -
franklin india small cap ... - - 1.29 - -
government of singapore -... - - 2.90 - -
icici prudential mutual f... - - 4.50 - -
lici new endowment plus-g... 1.78 1.78 1.78 - -
mirae asset large & midca... - - 4.49 - -
nippon life india trustee... - - 3.88 - -
uti focused fund - - 1.46 - -
franklin india flexi cap ... - 1.19 - - -
icici prudential elss tax... - 4.82 - - -
mirae asset arbitrage fun... - 3.06 - - -
nippon life india trustee... - 3.45 - - -
uti-flexi cap fund 1.50 1.54 - - -
icici prudential mutual f... 5.38 - - - -
independent directors 0.01 - - - -
mirae asset flexi cap fun... 3.92 - - - -
nippon life india trustee... 2.96 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY24
Concall Q1FY21
Concall Q1FY20
Concall Q3FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY26
Presentation Q3FY25
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY25
Presentation Q2FY25
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY26
Presentation Q1FY22
Presentation Q1FY21
Presentation Q1FY20

Company News

 No Latest News available for this company.Report us

Syngene Internatl. Stock Price Analysis and Quick Research Report. Is Syngene Internatl. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Syngene Internatl.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Syngene Internatl. has a PE ratio of 53.8381083514272 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Syngene Internatl. has ROA of 4.7435% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Syngene Internatl. has a Current ratio of 1.3223.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Syngene Internatl. has a ROE of 6.5763%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Syngene Internatl. has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Syngene Internatl. has reported revenue growth of 1.4971% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Syngene Internatl. for the current financial year is 23.6287166306443%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Syngene Internatl. is Rs 1.25 and the yield is 0.3074%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Syngene Internatl. is Rs 7.5532. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Syngene Internatl. in Ticker for free. Also, one can get the intrinsic value of Syngene Internatl. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Syngene Internatl. FAQs

Q1. What is Syngene Internatl. share price today?
Ans: The current share price of Syngene Internatl. is Rs 406.65.

Q2. What is the market capitalisation of Syngene Internatl.?
Ans: Syngene Internatl. has a market capitalisation of Rs 16415.205862755 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Syngene Internatl.?
Ans: The PE ratio of Syngene Internatl. is 53.8381083514272 and the P/B ratio of Syngene Internatl. is 3.52078531737717, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Syngene Internatl. share?
Ans: The 52-week high share price of Syngene Internatl. is Rs 728.6, and the 52-week low share price of Syngene Internatl. is Rs 380.

Q5. Does Syngene Internatl. pay dividends?
Ans: Currently, Syngene Internatl. pays dividends. Dividend yield of Syngene Internatl. is around 0.3074%.

Q6. What are the face value and book value of Syngene Internatl. shares?
Ans: The face value of Syngene Internatl. shares is Rs 10, while the book value per share of Syngene Internatl. is around Rs 115.4998. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Syngene Internatl.?
Ans: Syngene Internatl. has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Syngene Internatl.?
Ans: The ROE of Syngene Internatl. is 6.5763% and ROCE of Syngene Internatl. is 8.9188%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Syngene Internatl. a good buy for the long term?
Ans: The Syngene Internatl. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Syngene Internatl. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Syngene Internatl. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Syngene Internatl.’s financials?
Ans: You can review Syngene Internatl.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Syngene Internatl.
X